.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Farmers Insurance
Johnson and Johnson
Citi
Chinese Patent Office
UBS
Novartis
Teva
Baxter

Generated: December 13, 2017

DrugPatentWatch Database Preview

LYOPHILIZED CYTOXAN Drug Profile

« Back to Dashboard

When do Lyophilized Cytoxan patents expire, and when can generic versions of Lyophilized Cytoxan launch?

Lyophilized Cytoxan is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in LYOPHILIZED CYTOXAN is cyclophosphamide. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Drug patent expirations by year for LYOPHILIZED CYTOXAN

Pharmacology for LYOPHILIZED CYTOXAN

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

Medical Subject Heading (MeSH) Categories for LYOPHILIZED CYTOXAN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Baxter HlthcareLYOPHILIZED CYTOXANcyclophosphamideINJECTABLE;INJECTION012142-006Dec 5, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Baxter HlthcareLYOPHILIZED CYTOXANcyclophosphamideINJECTABLE;INJECTION012142-007Dec 10, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LYOPHILIZED CYTOXAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter HlthcareLYOPHILIZED CYTOXANcyclophosphamideINJECTABLE;INJECTION012142-006Dec 5, 1985► Subscribe► Subscribe
Baxter HlthcareLYOPHILIZED CYTOXANcyclophosphamideINJECTABLE;INJECTION012142-007Dec 10, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Cerilliant
Daiichi Sankyo
Julphar
US Department of Justice
AstraZeneca
Deloitte
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot